These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3973415)

  • 21. Production and characterization of monoclonal antibodies specific for types 6 and 19 pneumococcal capsular polysaccharides.
    Milligan GN; Braley-Mullen H
    Mol Immunol; 1989 Sep; 26(9):799-807. PubMed ID: 2601723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide.
    Paton JC; Lock RA; Lee CJ; Li JP; Berry AM; Mitchell TJ; Andrew PW; Hansman D; Boulnois GJ
    Infect Immun; 1991 Jul; 59(7):2297-304. PubMed ID: 2050399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T-cell modulation of the murine antibody response to Neisseria meningitidis group A capsular polysaccharide.
    Muller E; Apicella MA
    Infect Immun; 1988 Jan; 56(1):259-66. PubMed ID: 3121512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on vaccine control and immunogenicity of polysaccharides of Streptococcus pneumoniae.
    Lee CJ; Lin KT
    Rev Infect Dis; 1981; 3 Suppl():S51-60. PubMed ID: 6169130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of various adjuvants on the antibody response of mice to pneumococcal polysaccharides.
    Yin JZ; Bell MK; Thorbecke GJ
    J Biol Response Mod; 1989 Apr; 8(2):190-205. PubMed ID: 2659742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides undergo normal isotype switching after immunization with polysaccharide-protein conjugate vaccines.
    Shapiro DA; Threadgill DS; Copfer MJ; Corey DA; McCool TL; McCormick LL; Magnuson TR; Greenspan NS; Schreiber JR
    J Immunol; 1998 Oct; 161(7):3393-9. PubMed ID: 9759856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity differences of a 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15) based on vaccine dose, route of immunization and mouse strain.
    Caro-Aguilar I; Indrawati L; Kaufhold RM; Gaunt C; Zhang Y; Nawrocki DK; Giovarelli C; Winters MA; Smith WJ; Heinrichs J; Skinner JM
    Vaccine; 2017 Feb; 35(6):865-872. PubMed ID: 28087148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of the antibody response to pneumococcal polysaccharide by thymus-derived cells.
    Baker PJ; Amsbaugh DF; Stashak PW; Caldes G; Prescott B
    Rev Infect Dis; 1981; 3(2):332-41. PubMed ID: 6973183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary murine immunoglobulin M responses to certain pneumococcal capsular polysaccharides consist primarily of anti-pneumococcal cell wall carbohydrate antibodies.
    Fairchild RL; Sterner KE; Braley-Mullen H
    Infect Immun; 1986 Jun; 52(3):867-71. PubMed ID: 3710589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of the antibody response to type III pneumococcal polysaccharide (SSS-III). I. Use of 125I-labeled SSS-III to study serum antibody levels, as well as the distribution and excretion of antigen after immunization.
    Jones JM; Amsbaugh DF; Prescott B
    J Immunol; 1976 Jan; 116(1):41-51. PubMed ID: 1445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the induction of immunoglobulin M and G antibodies in mice with purified pneumococcal type 3 and meningococcal group C polysaccharides and their protein conjugates.
    Beuvery EC; van Rossum F; Nagel J
    Infect Immun; 1982 Jul; 37(1):15-22. PubMed ID: 6809623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. II. Relationship between IgM immunoglobulin levels and the ability to give an IgM antibody response.
    Amsbaugh DF; Hansen CT; Prescott B; Stashak PW; Asofsky R; Baker PJ
    J Exp Med; 1974 Jun; 139(6):1499-512. PubMed ID: 4151455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production, binding characteristics and protective immunity of monoclonal antibody to pneumococcal type-9V conjugate.
    Lee CJ; Karpas A; Wang TR; Kosaka T; Koizumi K
    Microbiol Immunol; 1996; 40(11):857-65. PubMed ID: 8985941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimal role for the spleen in antibody responses of C57BR/cdj mice to pneumococcal polysaccharide antigens.
    Cohn DA; Schiffman G
    Clin Exp Immunol; 1988 Apr; 72(1):151-6. PubMed ID: 3396216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic peptides representing T-cell epitopes act as carriers in pneumococcal polysaccharide conjugate vaccines.
    de Velasco EA; Merkus D; Anderton S; Verheul AF; Lizzio EF; Van der Zee R; Van Eden W; Hoffman T; Verhoef J; Snippe H
    Infect Immun; 1995 Mar; 63(3):961-8. PubMed ID: 7532630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the binding of and the immune response to pneumococcal group 9 capsular polysaccharides.
    Lu CH; Hugh R; Lee CJ
    Mol Immunol; 1987 May; 24(5):427-33. PubMed ID: 3657788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of a functionally distinct IgM anti-type III pneumococcal polysaccharide (SIII) in low-dose paralysis to SIII in mice.
    Kearney R; Andrews J; Johnstone S
    Aust J Exp Biol Med Sci; 1986 Feb; 64 ( Pt 1)():19-35. PubMed ID: 2938567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical structure of and immune response to polysaccharides of Streptococcus pneumoniae.
    Lee CJ; Fraser BA; Szu S; Lin KT
    Rev Infect Dis; 1981; 3(2):323-31. PubMed ID: 7020047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of immune responses to native and protein conjugated pneumococcal polysaccharide type 14.
    van den Dobbelsteen GP; Kroes H; van Rees EP
    Scand J Immunol; 1995 Mar; 41(3):273-80. PubMed ID: 7871387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in mice.
    Buchwald UK; Lees A; Steinitz M; Pirofski LA
    Infect Immun; 2005 Jan; 73(1):325-33. PubMed ID: 15618169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.